openPR Logo
Press release

OTC Cough, Cold, and Allergy Medicine Market: Antihistamine is Anticipated to Command for Over One-Third Revenues Share || Key Players: Johnson & Johnson Service, Inc., AstraZaneca Plc., Sanofi-Aventis, Sun Pharmaceutical Industries Ltd., Reckitt Benckise

04-09-2019 07:59 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

OTC Cough, Cold, and Allergy Medicine Market: Antihistamine

 There has been a notable transformation in the OTC cough, cold, and allergy medicines market, on the back of growing consciousness among medicine manufacturers to elevate the standards of their products, which in turn has positively influenced the market. Surging demands for effective drugs to cure inflammation among consumers is propelling the growth of the OTC cough, cold, and allergy medicine market at the global level.

Rising number of medicated consumers in concurrence to the increasing geriatric population at the global level is expected to remain a strong growth driver for this market. Additionally, demand from the consumers for these medicines is burgeoning rapidly, owing to the convenience of dosage in their fast-track life.

Request Sample here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=71

Asia Pacific excluding Japan (APEJ) is projected to enjoy supremacy over the global OTC cough, cold, and allergy medicine market, attributed to the pervasiveness of air pollution in the geography and the reception rate of these inexpensive and effective medicines is on a higher side. Pharmacies, being the most accessible channel for these medicines, is forecasted to lead among its counterpart distribution channels, reports Fact.MR. Aforementioned demand drivers have been evaluated and the market is predicted to register a remarkable CAGR of about 4.9% through 2022.

OTC Cough, Cold, and Allergy Medicine Market: Crux of the Report

The major aim of this comprehensive report is to assess the OTC cough, cold, & allergy medicines market at the global level for the duration 2017 to 2022. The study will help the suppliers, stakeholders, and manufacturers of this market gain accurate analysis of the market. A detailed executive summary has been incorporated in the report, which draws the attention of the stakeholders towards statistics and important facts on the market.

Browse Full Report on OTC Cough, Cold, and Allergy Medicine Market with TOC

https://www.factmr.com/report/71/otc-cough-cold-allergy-medicine-market

The study extends its focus on the market drivers, opportunities, restraints, key trends, and recent developments in the market during the forecasted period. The study comprises of various macroeconomic and microeconomic factors and demand & supply trend analysis to offer a thorough understanding of this market. Market segmentation has been done on the basis of OTC channel, drug type, region, and dosage, which has been analyzed in the report. The report has been curated by culling important information from the primary and secondary sources.

OTC Cough, Cold, and Allergy Medicine Market: Regional Segmentation and Competitive Dynamics

The market has been divided into Latin America, Europe, North America, Japan, Asia Pacific excluding Japan (APEJ), and Middle East and Africa (MEA). The region-based classification is detailed in nature and offers a country-specific forecast on various parameters.

The leading players in the market comprises of Johnson & Johnson Service, Inc., AstraZaneca Plc., Sanofi-Aventis, Sun Pharmaceutical Industries Ltd., Reckitt Benckiser Group Plc., GlaxoSmithKline Plc., Novartis AG, Prestige Brands Holdings, Inc., Bristol-Myers Squib Co., Procter & Gamble Co., Pfizer Inc., Allergen, and Merck & Co. A comprehensive information on pricing analysis, product sourcing, and cost structure has been incorporated in the report for each of these leading players, which will help the manufacturers and suppliers of the industry devise sustainable business strategies.

For More Information Raise Enquiry

https://www.factmr.com/connectus/sample?flag=AE&rep_id=71

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OTC Cough, Cold, and Allergy Medicine Market: Antihistamine is Anticipated to Command for Over One-Third Revenues Share || Key Players: Johnson & Johnson Service, Inc., AstraZaneca Plc., Sanofi-Aventis, Sun Pharmaceutical Industries Ltd., Reckitt Benckise here

News-ID: 1694216 • Views:

More Releases from Fact.MR

USA Demand for Microbiome Skincare Products in USA Outlook 2025-2035: Key Developments and Future Scope
USA Demand for Microbiome Skincare Products in USA Outlook 2025-2035: Key Develo …
The U.S. microbiome skincare market is projected to experience rapid, data-driven growth over the next decade, driven by rising consumer awareness, ingredient innovation, and the integration of personalized diagnostics. Analysts estimate the U.S. microbiome skincare segment at approximately USD 0.13 billion in 2025, with a projected increase to USD 0.35 billion by 2035, representing a compound annual growth rate (CAGR) of 10.4%. To access the complete data tables and in-depth insights,
USA Demand for Lubricants in USA Outlook 2025-2035: Key Developments and Future Scope
USA Demand for Lubricants in USA Outlook 2025-2035: Key Developments and Future …
The U.S. lubricants market is projected to experience steady growth through 2035, driven by shifts in mobility, industrial demand, and sustainability trends. The market was valued at approximately $41.2 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 2.5%, reaching $52 billion by 2035. To access the complete data tables and in-depth insights, request a Discount On The Report here: https://www.factmr.com/connectus/sample?flag=S&rep_id=12463
European Demand for Intermodal Freight Transportation in UK Outlook 2025-2035: Key Developments and Future Scope
European Demand for Intermodal Freight Transportation in UK Outlook 2025-2035: K …
"Demand for intermodal freight transport connecting the UK and continental Europe is projected to grow at a CAGR of 6.8% between 2025 and 2035, driven by rising trade volumes, decarbonization mandates, and digital logistics innovations. The intermodal market, encompassing rail, short-sea shipping, and last-mile road delivery, is expected to handle over 18 million TEUs (twenty-foot equivalent units) annually by 2035, up from 10.2 million TEUs in 2025. To access the complete
USA Demand for Hydroxyapatite in USA Outlook 2025-2035: Key Developments and Future Scope
USA Demand for Hydroxyapatite in USA Outlook 2025-2035: Key Developments and Fut …
The United States hydroxyapatite (HAp) market is projected to experience sustained, data-driven growth from 2025 through 2035, fueled by rising clinical demand, technological innovation, and expanded applications in regenerative medicine. Market modeling indicates that U.S. consumption of hydroxyapatite will nearly double over the next decade, with strong adoption in orthopedic, dental, and advanced biomaterial sectors. To access the complete data tables and in-depth insights, request a Discount On The Report here:

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to